Intraoperative Radiotherapy in Treating Spinal Metastases

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-75
SponsorShanghai Changzheng Hospital

About this trial

In order to provide theoretical evidence for the comprehensive and standardized treatment of spinal metastases with pathological fractures and/or spinal cord compression, the investigators conduct this trial to investigate the efficacy and safety of IORT and postoperative SBRT in adjuvant treatment of metastatic spinal tumors after posterior decompression surgery by recruiting patients with spinal metastases who met the inclusion criteria, and randomly divided them into the following treatment cohorts: 1) decompression surgery + IORT (15-20 Gy, 20-50min); 2) decompression surgery and postoperative SBRT(30Gy, 5 fractions, 3 weeks).

Eligibility criteria

Qualifiers

Clinical diagnosis of spinal metastases;

Estimated survival time more than 3 months;

The spinal instability neoplastic score (SINS) >12;

The general condition allows to recieve surgery;

Disqualifiers

Clinical diagnosis of primary spinal tumors;

Presence of metastases in central nerve system;

Isolated lesion undergoing en bloc resection;

Mental disorder and/or intellectual dificiency;

Trial design

Treatments tested in this trial

  • Intraoperative radiotherapy (IORT)
  • Stereotactic body radiotherapy (SBRT)

Treatment groups

132 Participants
are divided into 2 treatment groups

Sponsors and collaborators